ScoreWhy is Coherus BioSciences, Inc. ?
1
The company declared very negative results in Mar'25 after negative results in Dec'24
- NET PROFIT(HY) At USD -87.28 MM has Grown at -690.43%
- NET SALES(Q) At USD 11.57 MM has Fallen at -67.58%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.92 times
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 71.27%, its profits have fallen by -1015%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Coherus BioSciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Coherus BioSciences, Inc.
71.27%
-0.14
87.96%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-29.77%
EBIT Growth (5y)
-198.18%
EBIT to Interest (avg)
-5.25
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.17
Sales to Capital Employed (avg)
1.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
61.12%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.83
EV to EBIT
-0.65
EV to EBITDA
-0.67
EV to Capital Employed
-2.13
EV to Sales
1.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-203.60%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -87.28 MM
RAW MATERIAL COST(Y)
Fallen by -106.61% (YoY
-23What is not working for the Company
NET PROFIT(HY)
At USD -87.28 MM has Grown at -690.43%
NET SALES(Q)
At USD 11.57 MM has Fallen at -67.58%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.92 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.37 times
Here's what is working for Coherus BioSciences, Inc.
Net Profit
Higher at USD -87.28 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Raw Material Cost
Fallen by -106.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Coherus BioSciences, Inc.
Net Profit
At USD -87.28 MM has Grown at -690.43%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Net Sales
At USD 11.57 MM has Fallen at -67.58%
over average net sales of the previous four periods of USD 35.69 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Inventory Turnover Ratio
Lowest at 1.92 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 0.37 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
